Clinical trial
Theophylline in Chronic Obstructive Pulmonary Disease
NCT00299858 · Ottawa Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00299858 |
|---|---|
| Title | Theophylline in Chronic Obstructive Pulmonary Disease |
| Official title | Effect of Theophylline on Exercise Capacity and Lung Function in COPD Patients Receiving Long-acting Inhaled Bronchodilator Therapy |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Collaborators | Ontario Lung Association |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | Theophylline |
| Enrollment | 24 |
| Start date | Oct 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Mar 7, 2006 |
| Last update posted | Jul 7, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: